Related Experiment Videos
Familial chronic lymphocytic leukaemia: a survey and review of published studies
M R Yuille1, E Matutes, A Marossy
1Academic Department of Haematology and Cytogenetics and Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.
Insights
Genetic factors likely contribute to B-cell chronic lymphocytic leukemia (CLL), the most common leukemia. Family history surveys and published data suggest a genetic predisposition may play a role in a subset of CLL cases.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- B-cell chronic lymphocytic leukemia (CLL) is the most prevalent form of leukemia.
- Understanding the role of inherited factors in CLL etiology is crucial for disease management and prevention.
- Previous studies have suggested a potential familial component in CLL development.
Purpose of the Study:
- To investigate the role of inherited factors in the development of B-cell chronic lymphocytic leukemia (CLL).
- To evaluate the evidence for a genetic predisposition in a subset of CLL patients.
Main Methods:
- Conducted a survey of family histories in 268 CLL patients.
- Reviewed published literature on familial CLL cases.
- Analyzed epidemiological studies related to CLL inheritance patterns.
Main Results:
- Survey results and published data strongly support a genetic predisposition in a subset of CLL cases.
- The findings suggest that inherited factors contribute to CLL development.
- Evidence points towards dominantly acting genes with pleiotropic effects as a likely genetic model.
Conclusions:
- A subset of B-cell chronic lymphocytic leukemia (CLL) cases can be attributed to genetic predisposition.
- Dominantly acting genes with pleiotropic effects are the most probable genetic model for inherited CLL.
- The association of CLL with other lymphoproliferative disorders in families supports the proposed genetic model.
Abstract:
B-cell chronic lymphocytic leukaemia (CLL) is the most common form of leukaemia. To gain insight into the role of inherited factors in the disease, we have conducted a survey of the family histories of 268 CLL patients and have reviewed published familial cases and epidemiological studies. The results of our survey and published studies strongly support the hypothesis that a subset of the disease can be ascribed to a genetic predisposition. The most likely genetic model for inherited predisposition appears to be dominantly acting genes with pleiotropic effects because in many families CLL appears to be associated with other lymphoproliferative disorders.